Literature DB >> 2467497

Molecular heterogeneity of beta-thalassemia intermedia in Turkey.

A Gurgey1, C Altay, J C Diaz-Chico, F Kutlar, A Kutlar, T H Huisman.   

Abstract

A total of 38 patients with beta-thalassemia intermedia from 30 families were were studied. Twelve of the thirty unrelated patients had beta zero-thalassemia which was due to a homozygosity for one of two different thalassemia defects, namely the frameshift at codon 8, and the IVS-II-1 G----A mutation. Another mild variation, a beta +-thalassemia, was a homozygosity for the mutation of T----C at position 6 of IVS-1 (10 patients). Compound heterozygosities for mild thalassemic determinants or for one mild and one severe beta-thalassemic determinant were also found in some patients with beta-thalassemia intermedia. The mutations at beta-39 and IVS-I-110 were the most commonly occurring thalassemic determinants in these patients. Correlations between genotype and phenotype indicated significant differences in some of the hematological parameters among patients with the IVS-I-6 and the frameshift at codon 8, IVS-I-6 and IVS-II-1, and the frameshift at codon 8 and IVS-II-1 mutations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467497     DOI: 10.1159/000205394

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  2 in total

1.  The molecular basis of beta-thalassemia in Turkey.

Authors:  A N Başak; H Ozçelik; A Ozer; A Tolun; M Aksoy; L Ağaoğlu; F Ridolfi; L Ulukutlu; N Akar; A Gürgey
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

2.  Sickle cell anemia, sickle cell beta-thalassemia, and thalassemia major in Albania: characterization of mutations.

Authors:  E Boletini; M Svobodova; V Divoky; E Baysal; M A Cürük; A J Dimovski; R Liang; A D Adekile; T H Huisman
Journal:  Hum Genet       Date:  1994-02       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.